The University of Chicago Header Logo

Connection

Valluvan Jeevanandam to Retrospective Studies

Back to Details
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Retrospective Studies.
Valluvan Jeevanandam
Connection Strength
1.677
Retrospective Studies
  1. Does PTFE coverage facilitate LVAD explant and heart transplant? J Card Surg. 2022 12; 37(12):4324.
    View in: PubMed
    Score: 0.073
  2. Anemia and outcomes following left ventricular assist device implantation. Artif Organs. 2022 Aug; 46(8):1626-1635.
    View in: PubMed
    Score: 0.070
  3. Improving the metrics for donor heart sizing. J Card Surg. 2021 Sep; 36(9):3250.
    View in: PubMed
    Score: 0.067
  4. A model for continued LVAD patient success: A 4-year readmission-free HeartMate 3 postoperative course. J Card Surg. 2021 Mar; 36(3):1159-1161.
    View in: PubMed
    Score: 0.065
  5. Impact of plasma volume status on mortality following left ventricular assist device implantation. Artif Organs. 2021 Jun; 45(6):587-592.
    View in: PubMed
    Score: 0.065
  6. Winter LVAD implantation is associated with adverse clinical outcomes. Int J Artif Organs. 2021 Mar; 44(3):188-193.
    View in: PubMed
    Score: 0.063
  7. Sex difference in the impact of smoking on left ventricular assist device outcomes. J Card Surg. 2020 Nov; 35(11):2913-2919.
    View in: PubMed
    Score: 0.063
  8. Opioid Use and Morbidities during Left Ventricular Assist Device Support. Int Heart J. 2020 May 30; 61(3):547-552.
    View in: PubMed
    Score: 0.062
  9. Effect of tobacco smoking on outcomes after left ventricular assist device implantation. Artif Organs. 2020 Jul; 44(7):693-699.
    View in: PubMed
    Score: 0.061
  10. Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2017 Mar 08; 6(3).
    View in: PubMed
    Score: 0.050
  11. Complex Tricuspid Valve Repair in Patients With Pacer Defibrillator-Related Tricuspid Regurgitation. Ann Thorac Surg. 2016 Apr; 101(4):1599-601.
    View in: PubMed
    Score: 0.046
  12. The Subclavian Intraaortic Balloon Pump: A Compelling Bridge Device for Advanced Heart Failure. Ann Thorac Surg. 2015 Dec; 100(6):2151-7; discussion 2157-8.
    View in: PubMed
    Score: 0.044
  13. Cardiovascular surgery in Jehovah's Witness patients: The role of preoperative optimization. J Thorac Cardiovasc Surg. 2015 Oct; 150(4):976-83.e1-3.
    View in: PubMed
    Score: 0.044
  14. Durability of De Vega tricuspid valve annuloplasty for severe tricuspid regurgitation during left ventricular assist device implantation. Ann Thorac Surg. 2014 Jul; 98(1):81-3.
    View in: PubMed
    Score: 0.041
  15. Transapical approach for mitral valve repair during insertion of a left ventricular assist device. ScientificWorldJournal. 2013; 2013:925310.
    View in: PubMed
    Score: 0.038
  16. Beating heart totally endoscopic coronary artery bypass. Ann Thorac Surg. 2010 Jun; 89(6):1873-9; discussion 1879-80.
    View in: PubMed
    Score: 0.031
  17. Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
    View in: PubMed
    Score: 0.020
  18. Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
    View in: PubMed
    Score: 0.019
  19. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.018
  20. Decreasing blood wastage during ex vivo lung perfusion recovery through utilization of thermal control technology. J Card Surg. 2022 Dec; 37(12):5011-5018.
    View in: PubMed
    Score: 0.018
  21. Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
    View in: PubMed
    Score: 0.018
  22. Comparing short-term/long-term outcomes of heart transplants that occur inside and outside of normal working hours. ESC Heart Fail. 2022 08; 9(4):2484-2490.
    View in: PubMed
    Score: 0.018
  23. Surgical Correction of Spontaneous Outflow Graft Twisting of HeartMate 3 LVAD via a Subcostal Approach. Heart Surg Forum. 2022 Feb 28; 25(1):E152-E154.
    View in: PubMed
    Score: 0.018
  24. Combined heart-liver-kidney transplant: The university of Chicago medicine experience. Clin Transplant. 2022 04; 36(4):e14586.
    View in: PubMed
    Score: 0.017
  25. Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg. 2022 Jul; 83:42-52.
    View in: PubMed
    Score: 0.017
  26. Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure. J Cardiol. 2022 05; 79(5):611-617.
    View in: PubMed
    Score: 0.017
  27. Proximal ascending aorta size is associated with the incidence of de novo aortic insufficiency with left ventricular assist device. Heart Vessels. 2022 Apr; 37(4):647-653.
    View in: PubMed
    Score: 0.017
  28. Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure. Clin Cardiol. 2021 May; 44(5):636-645.
    View in: PubMed
    Score: 0.016
  29. Alternate Approach to Concomitant Carotid and Coronary Disease: Perioperative IABP Use during Carotid Endarterectomy. Ann Vasc Surg. 2021 Apr; 72:663.e9-663.e13.
    View in: PubMed
    Score: 0.016
  30. Impact of worsening of aortic insufficiency during HeartMate 3 LVAD support. Artif Organs. 2021 Mar; 45(3):297-302.
    View in: PubMed
    Score: 0.016
  31. A proposed redosing interval of del Nido cardioplegia solution in adult cardiac surgery: a propensity-matched study. Perfusion. 2021 Jul; 36(5):463-469.
    View in: PubMed
    Score: 0.016
  32. Outcomes of Ambulatory Axillary Intraaortic Balloon Pump as a Bridge to Heart Transplantation. Ann Thorac Surg. 2021 04; 111(4):1264-1270.
    View in: PubMed
    Score: 0.016
  33. Neurohormonal Blockade During Left Ventricular Assist Device Support. ASAIO J. 2020 08; 66(8):881-885.
    View in: PubMed
    Score: 0.016
  34. Optimal cannula positioning of HeartMate 3 left ventricular assist device. Artif Organs. 2020 Dec; 44(12):e509-e519.
    View in: PubMed
    Score: 0.016
  35. Aortic Insufficiency During HeartMate 3 Left Ventricular Assist Device Support. J Card Fail. 2020 Oct; 26(10):863-869.
    View in: PubMed
    Score: 0.015
  36. Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices. ASAIO J. 2020 03; 66(3):253-257.
    View in: PubMed
    Score: 0.015
  37. Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020 09; 110(3):918-924.
    View in: PubMed
    Score: 0.015
  38. HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse Events. Ann Thorac Surg. 2020 09; 110(3):911-917.
    View in: PubMed
    Score: 0.015
  39. Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation. J Card Fail. 2020 May; 26(5):383-390.
    View in: PubMed
    Score: 0.015
  40. Deep Y-Descent in Right Atrial Waveforms Following Left Ventricular Assist Device Implantation. J Card Fail. 2020 Apr; 26(4):360-367.
    View in: PubMed
    Score: 0.015
  41. Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? ASAIO J. 2020 01; 66(1):32-37.
    View in: PubMed
    Score: 0.015
  42. Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis. Artif Organs. 2020 Apr; 44(4):367-374.
    View in: PubMed
    Score: 0.015
  43. Increasing heart transplant donor pool by liberalization of size matching. J Heart Lung Transplant. 2019 11; 38(11):1197-1205.
    View in: PubMed
    Score: 0.015
  44. Aortic Insufficiency and Hemocompatibility-related Adverse Events in Patients with Left Ventricular Assist Devices. J Card Fail. 2019 Oct; 25(10):787-794.
    View in: PubMed
    Score: 0.015
  45. Novel Formula to Calculate Three-Dimensional Angle Between Inflow Cannula and Device Body of HeartMate II LVAD. Ann Thorac Surg. 2020 01; 109(1):63-68.
    View in: PubMed
    Score: 0.015
  46. A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical). J Artif Organs. 2019 Sep; 22(3):181-187.
    View in: PubMed
    Score: 0.014
  47. Home Inotropes in Patients Supported with Left Ventricular Assist Devices. ASAIO J. 2019 01; 65(1):e7-e11.
    View in: PubMed
    Score: 0.014
  48. Laparoscopic procedures in patients with cardiac ventricular assist devices. Surg Endosc. 2019 07; 33(7):2181-2186.
    View in: PubMed
    Score: 0.014
  49. Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events. Ann Thorac Surg. 2019 04; 107(4):1181-1186.
    View in: PubMed
    Score: 0.014
  50. Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
    View in: PubMed
    Score: 0.014
  51. Incidence and Outcomes of Postoperative Atrial Fibrillation After Left Ventricular Assist Device. ASAIO J. 2018 Sep/Oct; 64(5):581-585.
    View in: PubMed
    Score: 0.014
  52. Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2018 12; 106(6):1789-1796.
    View in: PubMed
    Score: 0.014
  53. Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices. J Card Fail. 2018 Sep; 24(9):561-567.
    View in: PubMed
    Score: 0.014
  54. Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
    View in: PubMed
    Score: 0.013
  55. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices. Dig Dis Sci. 2018 Jun; 63(6):1518-1524.
    View in: PubMed
    Score: 0.013
  56. Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail. 2018 Apr; 24(4):249-254.
    View in: PubMed
    Score: 0.013
  57. Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem. J Card Fail. 2018 02; 24(2):101-108.
    View in: PubMed
    Score: 0.013
  58. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
    View in: PubMed
    Score: 0.013
  59. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg. 1997 Jul; 64(1):142-7.
    View in: PubMed
    Score: 0.013
  60. Intravenous vitamin K1 prior to orthotopic heart transplantation: effects in vivo and in vitro. Acta Anaesthesiol Scand. 1997 Jan; 41(1 Pt 1):78-83.
    View in: PubMed
    Score: 0.012
  61. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996 Nov; 62(5):1268-75.
    View in: PubMed
    Score: 0.012
  62. PCI in Patients Supported With CF-LVADs: Indications, Safety, and Outcomes. J Invasive Cardiol. 2016 Jun; 28(6):238-42.
    View in: PubMed
    Score: 0.012
  63. Evidence supports severe renal insufficiency as a relative contraindication to heart transplantation. J Heart Lung Transplant. 2016 07; 35(7):893-900.
    View in: PubMed
    Score: 0.012
  64. Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. J Invasive Cardiol. 2016 Apr; 28(4):133-8.
    View in: PubMed
    Score: 0.012
  65. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016 Apr; 87(5):971-9.
    View in: PubMed
    Score: 0.011
  66. Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival. ASAIO J. 2014 Nov-Dec; 60(6):613-6.
    View in: PubMed
    Score: 0.011
  67. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014 Apr; 7(4):337-47.
    View in: PubMed
    Score: 0.010
  68. Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014; 39(3):195-203.
    View in: PubMed
    Score: 0.010
  69. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):951-5.
    View in: PubMed
    Score: 0.009
  70. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011 Aug; 92(2):520-7; discussion 527.
    View in: PubMed
    Score: 0.008
  71. Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am J Cardiol. 2010 May 01; 105(9):1339-42.
    View in: PubMed
    Score: 0.008
  72. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg. 2004 Aug; 26(2):367-72.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.